PureTech Health plc (NASDAQ:PRTC - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 35,900 shares, an increase of 77.7% from the December 15th total of 20,200 shares. Based on an average daily trading volume, of 4,500 shares, the days-to-cover ratio is presently 8.0 days.
PureTech Health Stock Performance
PureTech Health stock traded up $0.21 during trading on Wednesday, reaching $18.09. 9,526 shares of the company were exchanged, compared to its average volume of 3,181. PureTech Health has a 52-week low of $17.00 and a 52-week high of $34.00. The stock's 50 day simple moving average is $20.71 and its two-hundred day simple moving average is $21.16.
About PureTech Health
(
Get Free Report)
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Articles
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
